• Next Generation Sequencing (NGS) identifies genomic mutations in Head and Neck Squamous Cell Carcinoma (HNSCC), guiding personalized treatment approaches. • Customized immunotherapies or targeted treatments based on NGS data may improve HNSCC treatment outcomes. • NGS enables real-time monitoring of disease progression and treatment efficacy in HNSCC. • Cost remains a barrier to widespread NGS adoption for personalized HNSCC treatment.
No takes yet. Share an insight, caveat, or question.
Prasad et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: